Q&A

Using Zydis® ODT To Solve Delivery Challenges For Tolerogenic Vaccines

Source: Catalent
PIlls Blister Packaging GettyImages-174777552

Originally published in Pharmaceutical Technology.

Respiratory allergic disease is one of the most widespread chronic health conditions in the world, yet despite this prevalence, delivery formats for these therapeutics are surprisingly limited. The Zydis® orally dissolving tablet (ODT) platform from Catalent is a freeze-dried (lyophilized) oral solid dosage form that disperses instantly in the mouth and provides unique delivery routes for allergy immunotherapies.

Learn about the advantages offered by the freeze dried Zydis ODT relating to large molecule storage, aggregation, and in some cases, protease activity.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online